⌘K

Login Start Free

Home/Filings/4/0001062993-23-021981

4//SEC Filing

Luly Jay R. 4

Accession 0001062993-23-021981

CIK 0001177648other

View on SEC.gov Company Profile

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 9:08 PM ET

Size

4.7 KB

Accession

0001062993-23-021981

Insider Transaction Report

Form 4

Period: 2023-12-01

ENANTA PHARMACEUTICALS INCENTA

DirectorPresident and CEO

Transactions

Tax Payment
Common Stock
2023-12-01$9.49/sh−5,787$54,919→ 814,023 total

Footnotes (1)

[F1]Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit awards granted on November 20, 2020 and November 19, 2021.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

ENANTA PHARMACEUTICALS INC

CIK 0001177648

Entity typeother

Related Parties

1

filerCIK 0001571211

Filing Metadata

Form type: 4
Filed: Dec 4, 7:00 PM ET
Accepted: Dec 5, 9:08 PM ET
Size: 4.7 KB

View on SEC.gov